BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19382089)

  • 1. [Do convective treatments significantly reduce morbidity and mortality?].
    Manzoni C; Cavalli A; Pontoriero G; Di Filippo S; Locatelli F
    G Ital Nefrol; 2009; 26 Suppl 45():S16-9. PubMed ID: 19382089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can convective therapies improve dialysis outcomes?
    Locatelli F; Manzoni C; Cavalli A; Di Filippo S
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):476-80. PubMed ID: 19726986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-flux dialyzers, backfiltration, and dialysis fluid quality.
    Schiffl H
    Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are convective treatments equivalent to the traditional ones? The Hemo Study and beyond (review)].
    Altieri P; Sau G; Menneas A; Cabiddu G; Michittu MB; Mereu MC
    G Ital Nefrol; 2004; 21(3):245-53. PubMed ID: 15285003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study.
    Delmez JA; Yan G; Bailey J; Beck GJ; Beddhu S; Cheung AK; Kaysen GA; Levey AS; Sarnak MJ; Schwab SJ;
    Am J Kidney Dis; 2006 Jan; 47(1):131-8. PubMed ID: 16377394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study.
    Penne EL; Blankestijn PJ; Bots ML; van den Dorpel MA; Grooteman MP; Nubé MJ; ter Wee PM;
    Semin Dial; 2005; 18(1):47-51. PubMed ID: 15663765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantifying dialysis efficiency for middle molecules in haemodialysis and in convective and mixed techniques].
    Casino FG; Lopez T
    G Ital Nefrol; 2008; 25(1):66-75. PubMed ID: 18264920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical dialysis: new problems and new prospects].
    Locatelli F; Manzoni C; Pozzoni P; Pontoriero G; Di Filippo L
    G Ital Nefrol; 2004; 21(2):156-64. PubMed ID: 15351950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MPO Study: just a European HEMO Study or something very different?
    Locatelli F; Gauly A; Czekalski S; Hannedouche T; Jacobson SH; Loureiro A; Martin-Malo A; Papadimitriou M; Passlick-Deetjen J; Ronco C; Vanholder R; Wizemann V;
    Blood Purif; 2008; 26(1):100-4. PubMed ID: 18182806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are convective methods superior to diffusive dialytic methods?
    Cala S
    Acta Med Croatica; 2000; 54(1):21-5. PubMed ID: 10914437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti convection: convective therapies aren't the future of extracorporeal blood purification].
    Mandolfo S
    G Ital Nefrol; 2008; 25(4):396-402. PubMed ID: 18663686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis.
    Santoro A; Panzetta G; Tessitore N; Atti M; Mancini E; Esteban J; London G; Ara JM; Miguel JL; Neumann KH; Opatrny K; Perez R; Perrone B; Wizemann V; Zucchelli P
    J Nephrol; 1999; 12(6):375-82. PubMed ID: 10626827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study.
    Burrowes JD; Larive B; Chertow GM; Cockram DB; Dwyer JT; Greene T; Kusek JW; Leung J; Rocco MV;
    Nephrol Dial Transplant; 2005 Dec; 20(12):2765-74. PubMed ID: 16204298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pro convection: are convective therapies like hemodiafiltration and hemofiltration the future of extracorporeal blood purification?].
    Bolasco PG
    G Ital Nefrol; 2008; 25(4):389-95. PubMed ID: 18663685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk markers in hemodialysis].
    Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of high-efficiency hemodialysis treatments: long-term assessment.
    Bosch JP; Lew SQ; Barlee V; Mishkin GJ; von Albertini B
    Hemodial Int; 2006 Jan; 10(1):73-81. PubMed ID: 16441831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.